STOCKSURGICAL & MEDICAL INSTRUMENTS & APPARATUSUpdated 2026-05-03
Here’s whether Cerus Corp (CERS) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); strong 1-year return of +109.2%; 3-month momentum positive (+17.2%); rising volume confirms the move (1.72x 30d avg). Concerns: 50-day MA is falling (-2.25% over 10 days); RSI 80 — overbought, elevated pullback risk. Currently 13.7% off its 52-week high. Score: +4/7.
CERS is in a confirmed uptrend, trading above both its 50-day ($1.99) and 200-day ($1.79) moving averages. With an RSI of 79.8, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +109.2% compares to +27.9% for SPY (beat the market by 81.3%).
$10,000 invested 1 year ago→ $20,923 today
vs. S&P 500 (SPY) — same period beat market by 81.3%